arrow
M

Marco de Bruyn

university medical center groningen
H指数:38
被引数:6,499

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Lymph node involvement, surgery and adjuvant treatment in primary Endometrioid Ovarian carcinoma PAtients with eaRly-stage Disease (LEOPARD) - a multinational team initiative.

早期子宫内膜样卵巢癌患者淋巴结转移、手术及辅助治疗(LEOPARD)——一项跨国团队倡议

2026-05-050
OAAI
The Desert Immune Phenotype in Endometrial Carcinoma: A Distinct Subgroup With Poor Prognosis and Targetable Mutations

子宫内膜癌中的沙漠免疫表型:一个具有不良预后和可靶向突变的独特亚群

2026-04-100
OAAI
Multi-omic profiling and preclinical efficacy of fratricide-driven, unedited CD7 CAR-T cells in T-cell leukemia

多组学分析及 fratricide-driven、unedited CD7 CAR-T 细胞在T细胞白血病中的临床前疗效

2026-01-160
OAAI
Neo-Adjuvant Immune Checkpoint Inhibition In Endometrial Cancer Expands Transcriptional Footprints Associated With Tertiary Lymphoid Structures: Implications For Future Immunotherapy

新辅助免疫检查点抑制在子宫内膜癌中扩大与三级淋巴结构相关的转录印记:对未来免疫治疗的启示

2025-02-010
PRE
B cells critical for outcome in high grade serous ovarian carcinoma

B细胞对高级别浆液性卵巢癌的预后至关重要

2024-08-220
OAAI
Prediction of recurrence risk in endometrial cancer with multimodal deep learning (May, 10.1038/s41591-024-02993-w, 2024)
2024-07-010
OAAI
Immune predictors of response to immune checkpoint inhibitors in mismatch repair-deficient endometrial cancer

错配修复缺陷型子宫内膜癌对免疫检查点抑制剂反应的免疫预测因子

2024-07-011
OAAI
Prediction of recurrence risk in endometrial cancer with multimodal deep learning

多模态深度学习预测子宫内膜癌复发风险

2024-05-244
OAAI
Design, Synthesis, and Biological Evaluation of 2-Hydroxy-4-phenylthiophene-3-carbonitrile as PD-L1 Antagonist and Its Comparison to Available Small Molecular PD-L1 Inhibitors
2023-07-148
OAAI